Latest Blog Posts Tagged "Alpha-Synuclein"
June 13, 2014
A new study shows two avenues through which inhibiting the function of the protein LRRK2 may help treat people with Parkinson's, even those without a LRRK2 genetic mutation.
March 20, 2014
Journalist Jon Palfreman's book detailed a discovery that forever changed the face of Parkinson's research. Years later, Palfreman himself was diagnosed with Parkinson's disease.
September 13, 2013
The MJFF Research Tools Program recently marked some milestones in the ongoing effort to strategically grow the MJFF tools catalogue and improve understanding of current tools and their utility.
July 11, 2012
Today Xenoport announced funding from The Michael J. Fox Foundation (MJFF) to study a type of drug called a fumaric acid ester for its neuroprotective potential in Parkinson's disease.